Emerging Therapeutic Target ANGPTL4: A Key Molecule Linking Metabolism, Inflammation, and Tissue RemodelingAngiopoietin-like protein 4 (ANGPTL4) is a secreted glycoprotein expressed in multiple tissues, whose biological functions are highly dependent on tissue origin, proteolytic status, and pathological context. Studies have...
Detailed information

Research-Grade Biosimilar Antibodies: Practical Tools for Mechanism, Assay, and PK StudiesHave you ever had to scale back a promising experiment because the therapeutic antibody you needed was too expensive? You're not alone. Budget constraints force many researchers to compromise—fewer replicates, smaller ...
Detailed information

Client Literature Review IF=52.7: Targeting SKAP2 Restores Sperm Motility and Morphology by Regulating Mitochondrial Organization and Cytoskeletal RemodelingLiterature Title: SKAP2 restores sperm motility and morphology through modulating mitochondrial organization and cytoskeletal remodeling Journal: Signal Transduct Target Ther Impact Fact...
Detailed information

ANGPTL3: From Mechanisms to Clinics, Exploring a Novel Therapeutic Target for Cardiometabolic DiseasesANGPTL3 (Angiopoietin-like protein 3) is a hepatocyte-derived secreted protein that plays a central role in the regulation of lipoprotein metabolism. Substantial evidence from human genetics, molecular mechanism studies,...
Detailed information

ACVR1C/ALK7: An Emerging Target in Metabolic Diseases and Cancer TherapyACVR1C/ALK7, as a key member of the TGF-β superfamily, has recently garnered significant attention due to its dual roles in metabolic regulation and tumor progression. It not only plays crucial roles in adipose tissue d...
Detailed information

Beyond PD-1? The Potential and Breakthroughs of the Emerging Immune Checkpoint BTLAImmune checkpoint inhibitors, particularly those targeting the PD-1/PD-L1 pathway, have achieved groundbreaking progress in the field of cancer therapy. However, their limited response rates, the emergence of resistance,...
Detailed information

2026 Trends in Macromolecular Drug Targets: GLP-1 Deepening, Cardiovascular Remodeling, Immune Combinations, and the "Post-PD-1" EraIn the field of macromolecular drug development, one change is becoming increasingly evident: It's not that molecules can't be made, but rather that selecting targets is becoming increasingly difficult. ...
Detailed information

FCGR3A: A Key Receptor for Immune Regulation1. The Role and Importance of FCGR3A in the Immune System Immunoglobulin G Fc segment receptor III A (FCGR3A, also known as CD16a) is a crucial activating receptor expressed on the surface of Natural Killer (...
Detailed information

CRLF2 (TSLPR): A Key Target Linking Type 2 Inflammation to Hematologic MalignanciesThe thymic stromal lymphopoietin receptor (TSLPR, also known as CRLF2) is a key receptor subunit that mediates signaling by the epithelial-derived cytokine TSLP. Together with IL-7Rα, it forms a functional receptor comp...
Detailed information

The Multifaceted World of ADAM9: Beyond Proteolytic Function1. An Overview of ADAM9: Structure and Biological Functions ADAM9, a transmembrane multidomain protein, exhibits both disintegrin and metalloproteinase activities. These functions allow it to modulate a ...
Detailed information